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Previous studies from this laboratory have shown that there are striking similarities between the yellow chromophores, fluorophores and
modified amino acids released by proteolytic digestion from calf lens proteins ascorbylated in vitro and their counterparts isolated from aged and
cataractous lens proteins. The studies reported in this communication were conducted to further investigate whether ascorbic acid-mediated
modification of lens proteins could lead to the formation of lens protein aggregates capable of scattering visible light, similar to the high molecular
aggregates found in aged human lenses. Ascorbic acid, but not glucose, fructose, ribose or erythrulose, caused the aggregation of calf lens proteins
to proteins ranging from 2.2×106 up to 3.0×108 Da. This compared to proteins ranging from 1.8×106 up to 3.6×108 Da for the water-soluble
(WS) proteins isolated from aged human lenses. This aggregation was likely due to the glycation of lens crystallins because [U-14C] ascorbate was
incorporated into the aggregate fraction and because NaCNBH3, which reduces the initial Schiff base, prevented any protein aggregation. Reactions
of ascorbate with purified crystallin fractions showed little or no aggregation of α-crystallin, significant aggregation of βH-crystallin, but rapid
precipitation of purified βL- and γ-crystallin. The aggregation of lens proteins can be prevented by the binding of damaged crystallins to alpha-
crystallin due to its chaperone activity. Depending upon the ratios between the components of the incubation mixtures, α-crystallin prevented the
precipitation of the purified βL- and γ-crystallin fractions during ascorbylation. The addition of at least 20% of alpha-crystallin by weight into
glycation mixtures with βL-, or γ-crystallins completely inhibited protein precipitation, and increased the amount of the high molecular weight
aggregates in solution. Static and dynamic light scattering measurements of the supernatants from the ascorbic acid-modified mixtures of α- and
βL-, or γ-crystallins showed similar molar masses (up to 10
8 Da) and hydrodynamic diameter (up to 80 nm). These data support the hypothesis,
that if the lens reducing environment is compromised, the ascorbylation of lens crystallins can significantly change the short range interactions
between different classes of crystallins leading to protein aggregation, light scattering and eventually to senile cataract formation.
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During aging and cataractogenesis, the human lens exhibits
increased aggregation of the structural proteins [1,2], an
increasing amount of water-insoluble proteins that form upon
homogenization and increased lens protein-associated modifi-
cations, protein crosslinking and non-tryptophan fluorescence
[3–5]. The aggregation of lens proteins is thought to initially be
prevented by the binding of partially denatured crystallins to
alpha-crystallin due to its intrinsic chaperone ability, however
the partially denaturated crystallins over time form high molec-⁎ Corresponding author. Tel.: +1 573 882 6092; fax: +1 573 884 4868.
E-mail address: ortwerthb@health.missouri.edu (B.J. Ortwerth).
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doi:10.1016/j.bbadis.2007.10.003ular weight aggregates (HMW) capable of scattering light. The
pioneering work by Benedek [6] and Libondi [7] showed the
presence of such aggregates in human lenses during early
cataract development. While aggregation of lens proteins may
be caused by numerous factors (e.g. deamidation [8,9], muta-
genesis [10,11], UV-light [12], disulfide formation [11], cross-
linking [13,14], temperature [15], in most cases the common
denominator is a chemical change in the structure of particular
amino acid residue(s) within the protein structure, which in turn
causes protein structure instability and unfolding.
On the other hand, HMW protein aggregates from human
aged and cataractous lens are profoundly modified according
to the reports from this laboratory [16–18] and the other labs
[19–22]. This fraction contains the bulk of the modifications,
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attached to amino acid residues. The role of these modifications
in the formation of HMW aggregates is not well understood.
The glycation of lenticular proteins has been suggested to be
responsible for the formation of a significant fraction of lens
protein modifications present in the aged human lenses and in
diabetic and brunescent cataractous lenses [16–25]. These types
of reactions occur primarily at Lys and Arg residues within
the lens proteins by a variety of sugar carbonyls and aldehydes
[16–25]. The presence of such adducts can cause lens protein
destabilization, unfolding and aggregation in vivo as has
already been shown in the rat diabetic lenses by Swamy and
Abraham [26] and for the lens proteins modified by sugars in
vitro [27].
Ascorbic acid, one of the major lenticular antioxidants, can be
readily oxidized [28–30] if the lens reducing environment is
compromised [31,32]. Under chronic oxidative stress (e.g. dia-
betes, UV-light, age, etc.) increased formation of dehydroascor-
bic acid has been reported [33] and the inability of glutathione to
completely reduce dehydroascorbic acid back to ascorbic acid
brings about the rapid formation of highly reactive carbonyls
from dehydroascorbate [34]. These events usually result in rapid
glycation of lens proteins and both metal-dependent and metal-
independent generation of superoxide anion as has been shown
in vitro [16,24,25,35–37] resembling the modifications of
lenticular proteins in vivo [38]. Specifically, Fan et al. showed
that increased uptake of ascorbic acid into mouse lenses [38] was
able to cause increased formation ofmodified lenticular proteins,
exhibiting characteristic browning and fluorescence. These
changes resemble closely those seen in crude lens proteins
ascorbylated in vitro and those present in the human lens during
normal aging and cataract formation. We have recently reported
that the majority of the yellow chromophores, fluorophores and
modified amino acids released by proteolytic digestion from
calf lens proteins ascorbylated in vitro have the same or sim-
ilar properties as their counterparts isolated from aging and
brunescent cataractous lens proteins as has been determined by
TLC, HPLC and a recently developed 2-D LC-MS method
[16,23–25,35]. All these amino acid modifications increased
with age in the normal human lens water-insoluble proteins and
in the proteins from brunescent cataractous lenses [23–25].
While it has already been established that advanced glycation
end products are present in human aging or cataractous lenses
and some of them can result from glycation by ascorbic acid
degradation products (pentosidine, LM-1, K2P, etc. [17,20–
22,38]), very little if anything is known about their influence on
lens crystallin stability and conformation. Thus, we conducted
this project to evaluate the ability of ascorbic acid-derived
glycation products covalently bound to the lens proteins to
initiate protein aggregation and the formation of HMW
aggregates capable of scattering visible light.
2. Materials and methods
De-ionized water (18 MΩ or greater) was used throughout this project. All
phosphate buffers employed in this project were treated with Chelex resin
(10.0 g/l, 200–400 mesh, Bio-Rad Laboratories, Richmond, CA) to remove
transient metal ion contaminants according the method of Dikalov, Vitek,Maples et al. [39]. D-(−) glucose (anhydrous; N99.5%; Glc), L-(+) ascorbic acid
sodium salt (N99.7%; Asc), D-(−) fructose (N99.5%; Fru), D-(−) ribose (N99%;
Rib), L-erythrulose (97%; Ery), methylglyoxal (40%; MGO), diethylenetriami-
nepentaacetic acid (N95%) (DTPA), Trizma (base), trichloroacetic acid (TCA)
and NaCNBH3 were purchased either from Sigma (St. Louis, MO), Fluka
or Aldrich (Milwaukee, WI). L-[U-14C] ascorbic acid was synthesized from
D-[U-14C] glucose by the method of Crawford and Crawford [40] as described
previously [41]. Tricarboxyethyl phosphine (TCEP) was obtained from
Molecular Probes (Eugene, OR). Superose 6 support and protein high molec-
ular weight gel filtration calibration kit (Aldolase 158 kDa, Catalase 232 kDa,
Ferritin 440 kDa, Thyroglobulin 669 kDa, and Blue Dextran 2000) were all
from Amersham Biosciences (Uppsala, Sweden).
2.1. Preparation of lens proteins
Fetal calf lenses were shipped in ice from PelFreeze (Rogers, AR) and stored
at −70 °C until use. The water-soluble (WS) fraction was prepared from the
outer cortex of thawed calf lenses. The cortex from 10 lenses were pooled and
homogenized in a 50-ml Dounce tissue homogenizer with ice-cold de-ionized
water. The homogenate was centrifuged at 27,000×g for 30 min at +4 °C. The
lens supernatant (CLP) was carefully collected and dialyzed against 5 mM
phosphate buffer (pH 7.0) and used for glycation experiments or for preparation
of the purified α-, β- and γ-crystallin fractions.
To isolate purified crystallins, calf lens water-soluble proteins (CLP) were
further dialyzed against 10 mM Tris buffer (pH 7.8) containing 1.0 mM TCEP to
reduce protein disulfides and preserve the protein SH- groups from being
oxidized. The reduced proteins were passed through a Sephadex G-200
(5×80 cm) column to separate α-, βH-, βL- and γ-crystallins using gravity flow.
The α-, βH-, βL- and γ-crystallins were concentrated using a 10-kDa cut off
filter and each pooled fraction was re-chromatographed on the Sephadex G-200
(5×80 cm) column under the same conditions. Each crystallin peak fraction was
pooled, concentrated again and dialyzed against de-ionized water containing
0.1 mM DTPA, pH 7.0 at 4 °C. The homogeneity and composition of each
preparation were confirmed by SDS-PAGE analysis.
2.2. Preparation of human lens water-soluble and water-insoluble
proteins
Intact human lenses (20–75 years old) and cataractous lens nuclei of Indian
origin (65–75 years old; type I–II cataract) were used. Each decapsulated lens
was homogenized in a 2-ml Dounce tissue homogenizer with ice-cold de-
ionized water. The homogenate was placed in 15-ml Corning centrifuge tubes
and centrifuged at 27,000×g for 30 min at +4 °C. The lens supernatant was
carefully collected with a pipette and dialyzed against 5 mM phosphate buffer
(pH 7.0). The lens protein precipitate was washed three times with ice-cold de-
ionized water and sonicated with 2.5 ml of 5 mM phosphate buffer (pH 7.0) for
10 min with cooling. A power setting of 4 (approximately 40W) and a 30% duty
cycle were used with Model 375 Cell Disruptor (Heat Systems Ultrasonics Inc.,
Plainview, NY). Protein concentrations in both water-soluble (WS) and water-
insoluble sonicated supernatant protein preparations (WISS) were measured by
the BCA method described by Pierce Chemical Co. (Rockford, IL) or by the
BioRad Bradford method (BioRad, Hercules, CA).
2.3. Glycation reactions of CLP with different sugars
All reaction mixtures contained 1.0 mM DTPA in Chelex-treated 0.1 M
phosphate buffer, pH 7.0, 10 mg/ml of CLP and either 100 mM glucose,
100 mM fructose, 100 mM ribose, 20 mM ascorbic acid, 20 mM erythrulose or
10 mM methylglyoxal in a total volume of 4.0 ml. Prior to incubation each
glycation mixture was sterile-filtered through a 0.22 μ syringe filter (Whatman)
into a 15-ml sterile polyethylene vial, sealed and incubated at 37 °C for a period
of time ranging from 0 to 4 weeks. At weekly intervals aliquots of the reaction
mixtures were withdrawn, dialyzed against 5 mM sodium phosphate buffer
(pH 7.0) and stored at 4 °C until further use. Control reactions incubated without
sugar were subjected to the same procedure.
Reaction mixtures (4.5 ml) containing CLP (10.0 mg/ml) and L-[U-14C]
ascorbic acid (20 mM, 5 μCi per reaction mixture) in 0.1 M phosphate Chelex-
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removed and chromatographed using a Superose 6 column (1×25 cm) eluted at
1.0 ml/min flow rate with 50 mM phosphate buffer (pH 7.0). Fractions (0.5 ml)
were collected and their absorbance at 280 nm and 330 nm was recorded. The
radioactivity of each fraction was determined using liquid scintillation counter
Tri-Carb 2100 TR (Packard Instruments Company, Downers Grove, IL).
2.4. Glycation reactions of CLP in the presence of ascorbic acid and
cyanoborohydride
All glycation mixtures (2.0 ml) contained dialyzed CLP (10 mg/ml), either
20 mM or 1 mM ascorbic acid in 0.1 M Chelex-treated phosphate buffer (pH 7.0)
containing 1 mM DTPA, both with and without 40 mM or 5 mM sodium
cyanoborohydride respectively. The pH of each reactionmixture was adjusted to 7.0
if necessary prior to incubation. The controls were identical except that they
contained no ascorbic acid. Each mixture was sterile-filtered through a Whatman
0.22 μm syringe filter into 4 ml sterile polyethylene vial, sealed, and incubated at
37 °C. After 4 weeks of incubation, the reaction mixtures were dialyzed against
5mMphosphate buffer (pH7.0) and stored at 4 °Cuntil Superose 6 chromatography.
2.5. α-Crystallin inhibition of ascorbic acid-mediated β- and
γ-crystallin precipitation during glycation reactions
Mixtures (2.0 ml) containing purified α-, βH-, βL- or γ-crystallin
preparations (10 mg/ml) and 20 mM ascorbic acid in 0.1 M Chelex-treated
phosphate buffer (pH 7.0) with 1 mM DTPA were sterile-filtered through a
Whatman 0.22 μm syringe filter into 4 ml sterile polyethylene vials, capped and
incubated at 37 °C for 1 week. The controls contained no ascorbic acid. Reaction
mixtures containing varying levels of α-crystallin with purified βH-, βL- or γ-
crystallins (10 mg/ml total protein concentration) and 20 mM ascorbic acid were
prepared as described above and incubated at 37 °C for 1 week. The ratios of α-
crystallin to β- or γ- crystallins were varied from 0:1; 1:50; 1:20; 1:10; 1:5, 1:2;
and 1:1 on a weight basis. The controls contained no ascorbic acid. At the end of
incubation the amount of precipitate in the mixtures was estimated by light
scattering of the suspended solution. Each vial was vortexed extensively and the
contents were then poured into a fluorescence cuvette. The cuvette was vortexed
again and the fluorescence at excitation and emission wavelengths set at 620 nm
was immediately measured. When all mixtures were centrifuged, the super-
natants were analyzed by Bradford and BCA assays for protein concentration
and HPLC gel permeation chromatography was carried out for molecular weight
determination.
Relative 90° light scattering measurements of crystallins incubated both in
the presence and in the absence of ascorbic acid were performed using a Hitachi
model F-2500 spectrofluorometer (Hitachi, Tokyo, Japan) by a modification of
the method of Tappan [42]. In brief, the excitation and emission wavelengthsFig. 1. Aggregation of CLP during incubation with 20 mM ascorbic acid in air at 37 °
The dashed curve— 0 day incubation, black rectangles— 1 week incubation, white
shows profile of absorbance at 280 nm whereas panel B shows the profile at 330 nmwere set at 620 nm in order to reduce the sensitivity of the method and to prevent
possible light interaction with the chromophores/fluorophores usually present in
ascorbylated proteins. The light scattering values of the thoroughly vortexed
reaction mixtures were taken using 1 cm path quartz cuvettes (fluorescence
cells). All the measurements were performed in triplicate.
Protein concentrations in the supernatants from the glycation mixtures and
the corresponding controls were determined after aliquots (100 μl) of the
supernatants were TCA-precipitated using ProteoPrep precipitation kit (Sigma,
St. Louis, MO). The precipitates were re-dissolved in 0.1 N NaOH and protein
concentrations were measured using BCA colorimetric method (Pierce
Chemical Co., Rockford, IL).
The quaternary structural parameters of native and ascorbylated crystallin
mixtures were determined by dynamic light scattering measurements. The
reaction mixtures were centrifuged at 10,000×g for 30 min at 4 °C. The super-
natants were further separated (125 μg/injection) using a TSKG5000PWXL size-
exclusion column (7.8×300mm, Tosoh Bioscience LLC,Montgomeryville, PA)
equilibrated with 50 mM phosphate buffer containing 150 mM NaCl (pH 7.0)
and operating at 0.75 ml/min flow rate using an HPLC system (Shimadzu
Scientific Instruments Inc.). The HPLC system was equipped with refractometer
and UV detectors (Shimadzu Scientific Instruments Inc.) as well as multi-angle
light scattering (DAWN) and quasi-elastic scattering detectors (Wyatt Technol-
ogies Corp., Santa Barbara, CA). The molar mass moments, hydrodynamic
radius and polydispersity values of each crystallin peak were determined using
ASTRA software (ver. 5.1.5) developed and supplied by Wyatt Technologies
Corp., Santa Barbara, CA.
SDS-PAGE was carried out according to Laemmli [43] using 10–14%
gradient gels. The BioRad Precision Plus Protein prestained proteins standards
kit was used during electrophoresis.3. Results
The incubation of calf lens proteins with 20 mM ascorbic
acid in the presence of air leads to the progressive formation of
protein HMW aggregates. Fig. 1A shows the separation of a
reaction mixture of CLP with 20 mM ascorbate on a Superose 6
size exclusion column (separation range 5×103–5×106 Da for
globular proteins). Samples were analyzed every week for the
duration of 4 weeks. As can be seen in Panel A, there was a
decrease in the native proteins within the first week of incu-
bation and the formation of a peak, with a molecular weight
somewhat larger than native α-crystallin. The MW of this peak
could be due to the chaperone activity of α-crystallin bindingC. Samples were taken weekly and chromatographed over a Superose 6 column.
rectangles— 2 week incubation, solid bold trace— 4 week incubation. Panel A
.
Fig. 2. Superose 6 column profiles of CLP incubated for 4 weeks both in the absence of any glycating agent (panel A) and in the presence of 20 mM ascorbic acid
(panel B), 100 mM ribose (panel C), 100 mM glucose (panel D), 100 mM fructose (panel E), 20 mM erythrulose (panel F) under aerobic conditions at 37 °C. The
dashed curves show protein concentration profiles (mg/ml) determined by BCA assay; the bold solid curves show absorbance at 280 nm; the thin solid curves show
absorbance at 330 nm.
Fig. 3. TSK G5000PWXL size-exclusion column elution profiles of CLP mixtures incubated for 4 weeks under aerobic conditions at 37 °C in the absence and in the
presence of 20 mM ascorbic acid, 100 mM ribose, 100 mM glucose, 20 mM erythrulose, 20 mM methylglyoxal are shown in panel A. Panel B shows the average
relative molecular weights of the protein peaks calculated using ASTRA software. For convenience, the elution profiles are divided into four zones: 8.3–9.6 min
(HMWaggregates), 9.7–11.5 min (α-crystallin-like fraction), 12.5–13.5 min (β−crystallin fraction) and 13.5–14.5 min (γ-crystallin fraction) and are shown as shaded
bars in panel A.
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Fig. 4. Superose 6 profile of CLP incubated in the presence of 20 mM [U-14C]
ascorbic acid for 4 weeks under aerobic conditions at 37 °C. Bold solid line—
elution profiles measured at 280 nm, thin solid line— elution profiles measured
at 330 nm and bold dash line shows radioactivity [U-14C] ascorbic acid
incorporation into the CLP.
26 M. Linetsky et al. / Biochimica et Biophysica Acta 1782 (2008) 22–34modified crystallins. Within the next 2 weeks this “larger than
α-crystallin peak” diminished and coincided with a significant
increase in HMW protein aggregates that eluted in the void
volume of the column. Panel B shows a significant time-
dependent increase in the absorbance at wavelength of 330 nm
of the HMW peaks from 2 to 4 weeks, which may reflect AGE
chromophore formation in the HMW aggregates.
Four-week incubations of CLP with ascorbate and four other
sugars (ribose, glucose, fructose and erythrulose, see Fig. 2),
revealed that only ascorbic acid caused the formation of a HMW
peak (Fig. 2B). Based on the calibration data of the Superose 6
column with the mixture of standard proteins (see Materials and
methods) and α-crystallin, all the HMW proteins eluted in
the fractions prior to 12.5 ml. Glucose (Fig. 2D) and fructose
(Fig. 2E) produced no HMW protein aggregates. Ribose
(Fig. 2C) and erythrulose (Fig. 2F) produced proteins on
average 10% larger than α-crystallin, but no HMW peak was
observed in these mixtures even though many sugars were
present at higher concentrations than ascorbic acid.
The protein concentration profile from the Superose 6
column of the 4-week incubation mixture of CLP and ascorbate
presented in Fig. 2B showed that approximately 10–15% of theFig. 5. Superose 6 elution profiles of CLP mixtures incubated for 4 weeks under aerob
ascorbate (panel B) and in the presence of 20 mM ascorbate together with 40 mM s
330 nm, grey line — elution profiles measured at 280 nm.CLP used for this reaction was present in the HMW peak. Given
that only ascorbic acid caused HMW aggregate formation in
CLP, these data suggest that ascorbate and its degradation
products form a unique set of modifications within the lens
proteins responsible for a change in aggregation properties of
these proteins. Similar results were obtained in a repeat experi-
ment with a separate CLP preparation incubated under the same
conditions and separated on G5000PWXL size-exclusion HPLC
column (separation range 5×104–1×107 Da) (Fig. 3). The
protein profiles generated during the separation of glycated CLP
were used to determine the relative molecular mass moments
and hydrodynamic radii of the protein aggregates formed.
Ascorbate was the only sugar that caused the formation of
HMW aggregates with CLP with an average molecular mass
moment of 7.3×106 ±0.03% Da (see Fig. 3), though the left
shoulder of the first peak of the CLP–ascorbate mixture extends
to a molecular weight of 1.5×107 Da. Ribose and erythrulose
caused the formation of protein aggregates with the average
molecular mass moments of 7.2–9.6×105 Da, which is only
slightly higher in molecular mass moments than α-crystallin
(7.6×105±0.03% Da). Glucose-modified CLP exhibited no
significant protein aggregation and was very similar to the
elution profile of CLP alone (see Fig. 3A). Incubation of CLP
with methylglyoxal showed an effect opposite to the effect
of ascorbic acid on CLP. It led to a significant decrease in the
α-crystallin peak exhibiting a slightly lower molecular mass
moment, possibly due to methylglyoxal-mediated disaggrega-
tion of the α-crystallin molecule.
To verify that ascorbylation of CLP causes the formation of
HMW aggregates due to the glycation by ascorbic acid, two
additional experiments were conducted. We repeated the experi-
ment described in Fig. 1 and incubated CLP with [U-14C]
ascorbic acid under the conditions described in Fig. 1. The
elution profile of exhaustively dialyzed ascorbylated CLP on a
Superose 6 column is essentially the same as the one seen in
Fig. 1. Ascorbic acid was covalently incorporated into the
HMW peak (approximately 10% of total radioactivity incorpo-
rated), presumably because of glycation (Fig. 4). The HMW
peak showed a significant absorbance at 330 nm, which alsoic conditions at 37 °C in the presence of 20 mM ascorbic acid (panel A), without
odium cyanoborohydride (panel C). Black line — elution profiles measured at
Fig. 6. Superose 6 column profiles of CLP incubated both in the absence (dashed
bold line) and in the presence of 1.0 mM ascorbic acid for 1 week (black
triangles), 4 weeks (thin solid line) and 4 weeks with 1.0 mM ascorbic acid in the
presence of 5 mM NaCNBH3 (white rectangles) under aerobic conditions at
37 °C. Bold solid line in this figure shows a profile of CLP incubated with
20 mM ascorbate under identical incubation conditions.
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formed by CLP ascorbylation. Clearly, initial glycation products
represented significant incorporation of [U-14C] ascorbate, butFig. 7. Comparisons of the TSK G5000PWXL size-exclusion elution profiles for asco
modified CLP and aged human lensWISS proteins (Panel B). Average molecular weig
and analyzed by ASTRA software.had little or no effect on aggregation. The elution profiles of
CLP mixtures incubated in the presence of ascorbate compared
to ascorbate together with sodium cyanoborohydride (see
Fig. 5) show that the presence of the Schiff's base reducing
agent in the reaction mixture significantly reduced the amount
of HMWaggregates formed in the glycation mixtures (compare
Panel A and Panel C in Fig. 5) arguing that the reduction of
early glycation products covalently attached to CLP prevented
the formation of advanced glycation end products and inhibited
HMW formation. Furthermore, the presence of the reducing
agent in the ascorbic acid–CLP mixture drastically abolished
the formation of UV-absorbing chromophores, which coincided
in time with the decrease in the formation of HMW aggregates
(see Fig. 5).
Ascorbate-induced aggregate formation was also shown
when CLP proteins were incubated at 37 °C under aerobic
conditions in the presence of 1.0 mM ascorbic acid (replenished
weekly) (see Fig. 6). Our data show that the incubation of CLP
with physiological concentrations of ascorbic acid [33] under
air produced HMW protein aggregates chromatographicallyrbate-modified CLP and aged human lens WS proteins (Panel A) and ascorbate-
hts of the proteins eluting in the shaded areas were determined by light scattering
Fig. 8. Gradient (10–14.5%) SDS-PAGE (reducing) of CLP incubated in the
absence (lane 1) and in the presence of 20 mM (lane 2) or 1 mM (lane 3) ascorbic
acid for 1 week at 37 °C; human agedWI sonicated lens proteins from 27-year-old
(lane 4), 60-year-old (lane 5), 70-year-old (lane 6) lenses; human cataractous (type
I–II cataract) WI sonicated lens proteins from 60-year-old (lane 7) and 69-year-old
(lane 8).
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20 mM ascorbate (see Figs. 2B and 3). Similar to the mixtures
containing 20 mM ascorbic acid (Fig. 5C), the presence of
NaCNBH3 in the 4-week incubation mixtures containing 1 mM
ascorbate completely inhibited the formation of the HMW
aggregates in ascorbylated CLP (Fig. 6).
Fig. 7A compares the profiles for ascorbate-modified
CLP and the water soluble (WS) fraction from aged human
lenses eluting from the TSK G5000PWXL column. Again, the
ascorbate-modified CLP exhibited a broad peak of absorbance
at 280 nm, whereas the human lens WS fraction showed a
plateau of protein with few discernable peaks. Analysis of the
molecular weight showed increasing aggregate size up to
108 Da in the earliest portions of both elution profiles. The WS
proteins had considerable amounts of native-sized crystallins,
whereas few of these remained in the ascorbate-modified CLP
sample. The large amount of aggregates in fraction II and III in
the ascorbate-modified CLP was not present in the WS fraction
from aged human lens. It was possible that these proteins became
selectively precipitated upon homogenization and entered the
water insoluble (WI) fraction. We, therefore, solubilized a WI
fraction from aged human lenses by sonication and separated
these solubilized proteins (WISS) on the TSK G5000PWXL
column. Panel 7B shows a comparison of this profile with the
ascorbate-modified CLP preparation. As can be seen, the WISS
fraction seemed to contain a distribution of HMW aggregates
similar to the ascorbate-modified CLP proteins. Apparently,
ascorbate glycation could account for the protein aggregation
seen in aged human lens, but the data for theWI fraction must be
viewed with caution, because the sonication, used for solubiliza-
tion may have led to disruption of larger aggregates present inTable 1
Protein distribution and molecular weights of different lens preparations
Crystallins Peak
number a
Peak average
MWb (Da)
Protein distribution b
(% by weight)
CLP III 8.0E+05 51
IV 3.0E+05 17
V 1.0E+05 18
VI 6.1E+04 13
CLP+Asc I 2.4E+07 b3
II 1.1E+07 21
III 2.8E+06 42
IV 1.6E+06 17
V 8.7E+05 10
VI 5.4E+05 9
WS(human) I 8.0E+07 3
II 1.4E+07 6
III 2.3E+06 17
IV 9.7E+05 26
V 6.1E+05 22
VI 7.3E+05 27
WISS(human) I 3.4E+07 8
II 6.2E+06 75
III 4.9E+06 17
a Peak I (6.8–8.5 min, HMW1); peak II (8.5–10 min, HMW2); peak III (10–
11.5 min, α-like); peak IV (11.5–12.5 min, βH-like); peak V (12.5–13.5 min,
βL-like); peak VI (13.5–14.5 min, γ-like).
b Results shown are the average of four experiments with different protein
preparations.the lens WI fraction. The average molecular mass of the various
fractions are shown in Table 1.
SDS-PAGE gel analysis under reducing conditions of 4-week
incubations of CLP in the presence of 20 or 1 mM ascorbic acid
shows the presence of similar crosslinked proteins on the top of
the gel (see lanes 2 and 3 in Fig. 8). This protein crosslinking is
concentration-dependent, because CLP incubated in the pre-
sence of 20 mM ascorbic acid showed a higher intensity HMW
bands near the top of the gel compared to the HMW bands from
1 mM ascorbic acid-incubated CLP. The appearance of highly
polymerized HMW aggregates from 4-week ascorbylated pro-
teins on the SDS-PAGE gel resembles very closely the electro-
phoretic behavior of WI proteins from human aged (lanes 5
and 6) and cataractous lenses (lanes 7 and 8), which may reflect
the similarities in their formation mechanisms. The presence of
traces of highly crosslinked HMW proteins can be seen even in
the electrophoresed WI lens proteins from young human lenses
(27 years old; see lane 4 in Fig. 8).
To further examine how ascorbylation influences the aggre-
gation properties of lenticular crystallins, purified α-, βH-, βL-
and γ-crystallin fractions were incubated for up to 3 weeks in
the presence of 20 mM ascorbic acid under aerobic conditions.
We observed that the incubation of βL- and γ-crystallin
fractions in the presence of ascorbate under air quickly led to
the precipitation of these proteins in the first 3–4 days of the
experiment (data not shown). The precipitation was ascorbate-
dependent, since no precipitate was formed in the α-, βH-, βL-
and γ-crystallin fractions even after 3 weeks of incubation in the
absence of ascorbic acid (data not shown). The precipitation
within the ascorbylated βL- and γ-crystallin fractions coincided
with an increase in the total light scattering of the re-suspended
precipitates according to 90° light scattering measurements
of ascorbylated crystallin solutions (see insets in Panel C and
Panel D in Fig. 9). No protein precipitates were formed with the
Fig. 9. HPLC size-exclusion chromatography of ascorbylated α- (panel A), βH- (panel B), βL- (panel C) and γ-crystallin (panel D) fractions separated on the TSK
G5000PWXL size-exclusion column. The inserts in the panels show light scattering (measured as a fluorescent intensity at excitation 620 nm and emission 620 nm) of
ascorbylated crystallin reaction mixtures, vortexed immediately before measurements to suspend precipitated WI proteins. Numbers above the bars in the insets show
the protein concentrations (mg/ml) determined by a BCA assay in supernatants of the reaction mixtures. Dark bars show CLP incubated with ascorbate, whereas white
bars show CLP incubated without ascorbate.
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up to 3 weeks (data not shown).
Static and dynamic light scattering measurements were
performed for fractions separated on an HPLC G5000PWXL
size-exclusion column. Precipitates from ascorbylated βL- and
γ-crystallins were removed by centrifugation at 10,000×g and
the supernatants were analyzed. Measurements (Fig. 9A,
Table 2) show that ascorbylation of α-crystallin for 3 weeks
caused only a slight increase in the molecular mass of the
aggregates (from 8×105 Da in the native α-crystallin to
1.00×106 Da in the ascorbylated α-crystallin) and only to a
marginal increase in hydrodynamic radius of ascorbylated α-
crystallin (9.3 nm for the native α-crystallin vs. 10.3 nm for the
ascorbylated α-crystallin). At the same time, ascorbylation for 0
to 3 weeks of the βH-crystallin fraction showed a progressive
increase in hydrodynamic radii of the HMW peaks with Rt 8.5–
10.0 min to 17.4 nm in the 3-week ascorbylated βH-crystallin
fraction. This corresponds to almost a ten-fold increase in the
average molecular mass moment of the HMWaggregates in βH-
crystallins (molecular mass moment for 3 weeks βH control of
1.6×105 ±0.02% Da vs. molecular mass moment 3-weekascorbylated βH of 2.1×10
6±0.01% Da; see Fig. 9B and
Table 2). The 2–3 fold increase in the HMW species correlated
with an almost 10-fold increase in 90° light scattering of 3-week
ascorbylated βH-crystallin solutions (see inset in Fig. 9B).
Separation of the proteins remaining in the supernatant of the
ascorbylated βL-crystallin fractions on the G5000PWXL size-
exclusion column shows that almost 69–78% of the protein was
lost due to ascorbate-mediated precipitation of the proteins
within the first week of the experiment (see inset in Fig. 9C). The
relative average molecular mass moment determination for the
prevalent species in these fractions (Rt 12–13 min) shows that
while the remaining βL-crystallins didn't increase in mass, the
average hydrodynamic radius of the 3-week ascorbylated species
in the major peak is increased about 3-fold, compared to 3-week
native βL-crystallin fraction incubated without ascorbate under
the same conditions (Fig. 9C). This increase in ascorbylated
βL-crystallin aggregation with time is in good agreement with
5-fold increase in the total 90° light scattering of whole 3-week
ascorbylated βH-crystallin solution (see inset in Fig. 9C).
Similar to βL-crystallins, ascorbylation of γ-crystallins
caused precipitation of almost 60% of the total protein within
Table 2
Quaternary properties of native and ascorbic acid-modified calf lens crystallins
Crystallins Peak number a MW (Da) Protein distribution
(% by weight) b
α (calf) III 7.79E+05
α+Asc III 8.9E+05
βH (calf) IV 1.59E+05
βH+Asc II–III 2.16E+06
βL (calf) V 5.8E+04 100
b
βL+Asc V 5.8E+04 22
b
γ (calf) VI 2.2E+04 100 b
γ+Asc VI 2.76E+04 35 b
α+βL(1:10)+Asc I 1.8E+07 15
II 1.32E+07 24
α+βL(1:5)+Asc I 1.5E+07 8
II 5.54E+06 53
α+γ(1:20)+Asc I 4.77E+07 6
II 2.1E+07 16
α+γ(1:10)+Asc I 4.98E+07 4
II 1.04E+07 20
α+γ(1:5)+Asc I 5.7E+07 2
II 8.69E+06 22
a Peak I (6.8–8.5 min, HMW1); peak II (8.5–10 min, HMW2); peak III (10–
11.5 min, α-like); peak IV (11.5–12.5 min, βH-like); peak V (12.5–13.5 min,
βL-like); peak VI (13.5–14.5 min, γ-like).
b Most of the crystallins was precipitated during glycation reactions; only a
fraction of the starting material (22% of starting 100% βL and 35% of starting
100% γ) was found in the solution at the end of the incubation period.
Fig. 10. HPLC profiles of undialized non- and ascorbylated α+γ - (panel A),
and α+βL–crystallin mixtures (panel B) separated on the TSK G5000PWXL
size-exclusion column (peak numbers are shown above the bars). Panel C shows
the light scattering (measured as a fluorescence intensity at excitation 620 nm
and emission 620 nm) of crystallin mixtures (I — α+γ; II — α+βL; III —
α+βL+βH+γ) incubated for 1 week at 37 °C both in the presence and in the
absence of ascorbic acid. Crystallin ratios were calculated by dividing the total
concentration (mg/ml) of βL or γ or βL+βH+γ crystallins by the concentration
(mg/ml) of α-crystallin in the corresponding reaction. The first number in
crystallin ratios stands for α and the second for βL or γ or βL+βH+γ.
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the 0–3 week supernatants supports this finding (see Fig. 9D).
The major species that remained soluble (Rt 12–13 min) in the
reaction mixtures exhibited an average molecular mass moment
of 2.7×104±0.02% Da for 0 week incubation compared to
3.2×104 ±0.03% Da at 3 weeks. Hydrodynamic radii ranged
from 1.1 to 7.8 nm after 3 weeks ascorbylation. It should be
noted that γ-crystallin mixtures ascorbylated for 2–3 weeks
contained trace amounts of aggregates with hydrodynamic radii
ranging up to 35 nm (see species with Rt 9.5–10.5 min), which
are of sufficient size to scatter visible light. The presence of
these species was probably responsible for excessive total 90°
light scattering of 1–3 week ascorbylated gamma-crystallin
solutions (see inset in Fig. 9D). Given that the major ascorbylated
γ-crystallins with hydrodynamic radii of 8 nm or less were found
in the 1–3 week ascorbylated γ-crystallin supernatants, it seems
that aggregates with larger radii were prone to precipitation.
Both the presence of protein precipitates in the 1–3 week
ascorbylated βL- and γ -crystallin fractions and the absence of
precipitates in ascorbylated CLP (see insets in Fig. 9C and D)
suggested that during glycation of CLP by ascorbate, α-crystallin
in the CLP interacted with the modified βL and γ-crystallins
because of its chaperone activity thereby preventing their
precipitation. We tested this hypothesis by ascorbylating βL and
γ-crystallin fractions in the presence of increasing amounts of
added α-crystallin for 1 week under air and monitoring the effect
on aggregation (see Fig. 10 and Table 2). At ratios ofα-crystallin:
βL- or γ-crystallin less than 1:10 we have observed only a partial
protection of ascorbylated βL- and γ-crystallins by α-crystallin.
Depending upon the concentration of α-crystallin added to these
mixtures approximately 30% to 50% of the protein precipitatedin these solutions within 1 week and they were characterized by
a 500–800 fold increase in the total 90° light scattering com-
pared with the control solutions incubated without ascorbic acid
under the same conditions (see Fig. 10C). Separation of the
proteins remaining in the supernatants of the ascorbylated βL-
crystallin and γ-crystallin samples in the presence of α-crystallin
showed the presence of aggregates with molecular massmoments
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ranging up to 40 nm ( Rt 6.5–8.2 min; see Fig. 10 Panel A and
Panel B and Table 2). It should be emphasized, that similar to the
HMW aggregates from α+βL- and α+γ-crystallins solutions
(with ratios higher than 1:5), human water-soluble crystallin
fraction from old (70–75 years old) lenses exhibited similar
chromatographic characteristics under the same separation
conditions. Depending upon the preparation, the peak at Rt 6.8–
8.0 min from the WS fraction from human lens showed visible
light scattering aggregates with molecular mass moments ranging
from 3.0×107±0.03% Da to 6.6×107±0.03% Da with hydro-
dynamic radii up to 40 nm.
With an increase in α-crystallin concentrations in both the
ascorbylated α-:βL and α-:γ-crystallins mixtures at ratios higher
than 1:5 we observed the complete disappearance of protein
precipitates, which coincided with a significant decrease in the
total 90° light scattering of the solutions (see Fig. 10C). At the
same time, at the ratios of α-: βL- and α-: γ-crystallins of 1:2 the
major HMW species had hydrodynamic radii within the range of
22–30 nm the average molecular mass moments ranging from
7×106 ±0.02% Da to 1.5×107 ±0.03% Da (Fig. 10A and B).
These species are very similar to the ones detected in the protein
water-insoluble sonicated (WISS) fractions from aged lenses.
The disappearance of the protein precipitates and significant
decrease in the size of the protein aggregates in the ascorbylated
α+βL- and α+γ-crystallin mixtures clearly shows that at high
α-crystallin to βL- and γ-crystallin ratios α-crystallin prevented
the formation of glycation-mediated βL- and γ-crystallin
precipitation, probably by binding (chaperoning) ascorbylated
βL- and γ-crystallins and preventing their aggregation. An
opposite effect occurred when the α-crystallin to βL and
γ-crystallin ratios drop lower than 1:5. Under these condi-
tions α-crystallin not only is ineffective as a chaperone for
ascorbylated βL and γ-crystallin, but also facilitates the for-
mation of HMW lens protein aggregates similar in mass and
size to the HMW aggregates from aged human lens water
soluble protein. (Fig. 10, Table 2).
4. Discussion
Short-range protein–protein interactions of lens crystallins
within the lens fiber cell are considered to be responsible for
lens transparency [44]. These forces are thought to be com-
promised in the lens due to post-translational crystallin modi-
fications that occur during normal aging of the lens and during
cataractogenesis [2,6,7]. Usually, such modifications (e.g.
methionine oxidation, formation of protein–protein disulfides
and GSH–protein mixed disulfides, non-enzymatic glycation,
phosphorylation, deamidation, truncation, etc.) lead to in-
creased protein–protein interactions and cause fluctuations in
the protein density within the lens [9,12,16,23,26,38,45].
Eventually, as the magnitude of these modifications increases,
it results in the formation of HMW aggregates capable of
scattering visible light impinging on the lens [2,6,7,45–47].
Interestingly, even a small number of such aggregates
present in apparently undamaged lens fiber cells can cause light
scattering in the guinea pig lenses treated with hyperbaricoxygen [48]. Similar HMWaggregates (slow diffusing species)
were observed in the human lenses with early cataracts and
according to Benedek [6] they correspond to aggregates with
approximate molecular mass of 5.0×107 Da (approximately
50 nm in diameter) and higher [46]. According to Bettelheim
et al. [49] and Liem et al. [50] these aggregates could reach
300–500 nm in diameter (apparent molecular mass 5×108 Da)
and higher in nuclear cataract and up to 1000 nm in diameter in
the X-ray induced cataract in rabbit lenses [50], respectively.
The data presented in this communication show that even WS
proteins from aged human lenses (70–75 years old) and early
(Type I) cataracts (data not shown) contain aggregates with
average mass moments ranging from 3.0 to 6.5×107 Da with
hydrodynamic radii ranging up to 40 nm (Fig. 9).
In their pioneering work Stevens et al. were the first to
recognize that sugar-mediated modifications of the Lys ε-amino
groups in lens crystallins can influence their functional prop-
erties, and they hypothesized that non-enzymatic glycation can
cause structural changes in lens proteins leading to their
insolubilization [51]. According to Swamy and Abraham, there
is a progressive and significant increase in the glycated HMW
proteins within rat lenses with time and with the severity of
sugar cataract in diabetic rats [26,52]. Similarly, human cata-
ractous lenses also show an increase in early glycation products
with age and an increase in fluorescent substances in certain
types of cataract [53]. There is a positive correlation between
the decrease in the content of Lys, Arg and His residues in lens
crystallins [53,54] and type I–II cataract formation [23–
25,54,55]. A similar correlation between lens protein glycation,
browning, fluorescence and age has been observed in human
lenses [16,23–25,56]. Based on data published in the literature,
the total levels of AGE modifications (e.g. CML, CEL, etc.) and
AGE crosslinks (e.g. K2P, MOLD, glucosepane, etc.) can reach
levels up to 7.5 nmol/mg of lens protein in cataractous lenses
and 4.1 nmol/mg of lens protein in aged human lenses (ages
60 years old and older) [16–25,57–66]. It should be noted that
most of these AGEs have been detected in WI lens proteins and
may represent a contributory factor in lens protein unfolding
and aggregation.
There is a growing body of evidence that ascorbic acid can
contribute to an overall lens predisposition to cataract forma-
tion. On one hand, aged and cataractous human lenses contain
increased levels of dehydroascorbic acid [33]. On the other
hand, the old and cataractous human lenses usually provide a
suitable environment for ascorbic acid oxidation. The condi-
tions that facilitate the oxidation of ascorbic acid in the lens
include diabetes and the formation of a dense barrier around the
lens nucleus [67], which causes a significant decrease in GSH
concentration in the lens nucleus. The other factors include the
low GSH levels within the lens and the lack of hexose
monophosphate shunt needed to synthesize NADPH, which is
needed for the normal function of glutathione reductase [68]. It
is quite possible that the low GSH levels in the nucleus lead to a
build up of ascorbic acid degradation products, including
dehydroascorbic acid (DHA), 2,3-diketogulonic acid and
erythrulose [34]. These intermediates are far more potent as
glycation agents, and under air ascorbic acid modifies lens
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rapidly than glucose [35]. The incubation of rabbit lens explants
in the presence of dehydroascorbic acid, along with suppressed
glutathione disulfide reduction by glutathione reductase, there-
fore culminated in the lens opacification within hours from the
beginning of the experiment [31]. Furthermore, an increased
influx of ascorbic acid to the mouse lens by an overexpressed
vitamin C SVCT2 transporter led to marked lens browning [38].
While the modifications of CLP by ascorbic acid produces
modified amino acids similar to those in aged human lenses and
cataract [16–18], it has not been shown that these glycation
modifications play a causal role in cataract formation. In the
communication presented here we have shown that ascorbic
acid-mediated modifications of individual calf lens crystallins
can induce their aggregation (Fig. 1) and precipitation (Fig. 9).
These results are in good agreement with the data from our
previous publication, which showed that ascorbic acid can
induce lens protein crosslinking and precipitation in lens
extracts at physiological vitamin C concentrations at pH 7 and
under limiting oxygen conditions [69]. This effect is sugar-
specific, because no other carbohydrate tested in this study was
able to produce HMW aggregates of CLP upon incubation
under aerobic conditions. Further, the aggregates produced by
ascorbate were similar in size to the combined aggregates
present in the sum of the WS and WI lens proteins from aged
human lenses (Fig. 7). Also, our results show that the presence
of NaCNBH3, an effective and specific Schiff's base reducing
agent, in the incubation mixtures almost completely prevented
the formation of the HMWaggregates in ascorbylated CLP. This
reagent reduces the early glycation products on proteins thereby
preventing the formation of AGEs. Consistent with this effect
was the diminished formation of UVA-absorbing AGEs (see
Fig. 5), which is indirect evidence for the presence of nitrogen-
containing heterocycles within ascorbylated CLP. The appear-
ance and the electrophoretic mobility of ascorbylated calf lens
proteins on the SDS-PAGE gel resemble closely those from the
WI proteins from aged and cataractous lenses (Fig. 8). These
coincides with the fact that there are close structural similarities
between the adducts covalently bound to proteins in ascorby-
lated CLP and the lens protein modifications found in aged
human lenses and in brunescent cataracts of Indian origin [16–
18,23–25].
The precipitation of βL- and γ-crystallins by ascorbic acid
occurs rather rapidly (within 2–3 days of incubation) and it
seems ascorbate-induced, since no precipitates were formed in
the βL- and γ-crystallin solutions kept under air and in the
absence of ascorbate even after 4 weeks of incubation at 37 °C
(Figs. 9 and 10). This effect resembles that observed by Swamy
and Abraham in the lenses of diabetic rats [26]. The cataractous
lenses of older hyperglycemic animals were shown to lose γ-
crystallins in the lens protein WS fraction with subsequent
accumulation of γ-crystallins in the urea-soluble fraction
(water-insoluble proteins). The effect was probably due to
lens protein glycation as well as oxidation, because the
acetylation of rat lens proteins the ε amino groups of lysine
significantly diminished the formation of HMWaggregates and
cataract formation in the diabetic rats [52].The interactions between α-crystallin and β- and γ-crystal-
lins are weak and usually do not produce any stable complexes
under physiological conditions [70,71]. This situation changes
when α-crystallin is present in βL- or γ-crystallins solution
under air in the presence of ascorbic acid. α-Crystallin dimin-
ished the formation of ascorbylated β- and γ-crystallins precip-
itates (Fig. 10). At lower α-crystallin to βL and γ-crystallins
ratios, there was a strong tendency to form aggregates with
molecular mass 3.0×107 Da to 7.0×107 Da and hydrodynamic
radii up to 40 nm similar to HMWaggregates in the aged human
lenses (70–75 years old) and early (Type I) cataracts. Thus, it
seems that α-crystallin exhibits its chaperone function toward
ascorbylated βL or γ-crystallins and forms complexes main-
taining them in solution. Once the chaperoning capacity of
α-crystallin is overwhelmed, soluble HMW aggregates are
formed. The proposed mechanism may also take place in rat
diabetic lenses. Lenses from rats with persistent moderate hyper-
glycemia have a significant amount of light scattering HMW
aggregates similar in composition to HMW aggregates from
human lens [72–74]. Crystallins isolated from those lenses
contain AGEs within their framework and show a tendency
to form HMW aggregates that scatter visible light [72–74],
however, unlike these aggregates, the ascorbylated aggregates
were completely resistant to reduction by the TCEP reducing
reagent.
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